Scientific Overview: AKT inhibitor; combined with carfilzomib in multiple myeloma. AKT + proteasome inhibitor combination

Mechanism of Action: Pan-AKT Inhibitor

Purity: ≥99%  |  Molecular Formula: C21H25ClN4O3S

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.

Request a Quote

0
For Research Use Only. Not for human or veterinary use. · COA, SDS, and ISO/GMP certificates provided on request.